The NHS-Galleri trial randomised 142,250 adults aged 50 to 77 in England to multicancer blood testing or usual care over three annual rounds. Incidence of stage III or IV cancer across 12 prespecified cancers did not differ between the groups, with a rate ratio of 1.03. For stage IV cancer alone, a secondary end point, the rate ratio was 0.86, with the confidence interval reaching 1.00.
Why it is interesting: A randomised trial of whether earlier detection shifts stage at diagnosis, rather than test accuracy.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.